WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 39  38  38  38  38  32  29  27 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for Monaco)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Monaco)
Vaccine year result method % card seen                                                
BCG          99* 
DTP1         
DTP3          99*  99* 
DTP4         
IPV1         
HepB_BD         
HepB3         
Hib3         
JapEnc         
MCV1          88  99* 
MCV2          79 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          99* 
Rota1         
RotaC         
RCV1          88 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Monaco)
BCG
ChartChart
  89  89  89  89  89  97  99 
DTP1
ChartChart
  99  99  99  99  99  99  99 
DTP3
ChartChart
  99  99  99  99  99  99  99 
HepB3
ChartChart
  99  99  99  99  99  99 
HepB_BD
 
Hib3
ChartChart
  99  99  99  99  99  99 
MCV1
ChartChart
  87  88  88  89  90  98  99 
MCV2
ChartChart
  79  79  79  79 
PCV3
 
Pol3
  99  99  99  99  99  99  99 
RCV1
ChartChart
  87  88  88  89  90  98  99 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepBIPV 2, 4, 16-18 months; Yes
DTaPHibIPV 3 months; Yes
DTaPIPV 11-13, 26-28 years; Yes
DTIPV 2, 4, 11 months; 6 years; Yes
HepB_Pediatric 2, 4, 11 months; Yes
HIB 2, 4, 11 months; Yes
HPV 11 years; +6 months Yes
Influenza Infants and adults at risk
IPV 26-28 years; Yes
MenC_conj 5, 12 months;
MMR 12, 16 months; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps population at risk
Rubella 12, 16 months;
TdaPIPV 26-28 years; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No             
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number            
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No             
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No             

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes             

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.